KorrekturOpen Access · CC BY 4.0
Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”
Molecular Oncology · 2026-08 · 20 (8) · 2129-2130
DOI: 10.1002/1878-0261.70297 ↗Kurz gefasst
Korrektur in der Zeitschrift Molecular Oncology, online erschienen am 12.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”. Molecular Oncology, 20(8), 2129-2130. https://doi.org/10.1002/1878-0261.70297
Vancouver
Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”. Molecular Oncology. 2026;20(8):2129-2130. doi:10.1002/1878-0261.70297
BibTeX
@article{euvimed2026,
title = {Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”},
journal = {Molecular Oncology},
year = {2026},
volume = {20},
number = {8},
pages = {2129--2130},
doi = {10.1002/1878-0261.70297}
}
EUVIMED